Burn Ointment Market Size was valued at USD 1.01 Billion in 2023 and is expected to reach USD 1.71 billion by 2032, growing at a CAGR of 6.04% over the forecast period 2024-2032.
This report offers useful insights into statistics and trends of the Burn Ointment Market, covering all the important aspects. This includes an evaluation of burn incidence, prevalence by severity and region. The report examines prescription trends by region, noting differences in hospital and OTC sales. It also analyzes drug volume when it comes to production and usage for market demand purposes. It also offers a breakdown of health care spending on burn treatments, by government, insurers, and out-of-pocket. Finally, it examines regional thematic regulatory permissions and compliance trends in end-user markets that are driving market growth and innovation. Furthermore, rising burn cases, along with improved awareness regarding burn treatment are some of the factors strengthening the growth of the burn ointment market. In the U.S., around 486,000 people have fire-related injuries each year, underscoring the importance of burn treatments. In recent years, the U.S. dominated the global market, accounting for 78% market share of North America, and held a USD 325 million revenue share in 2023 driven due to the country features advanced healthcare infrastructure and high cognizance of burn safety.
Driver
The increasing incidence of burn injuries globally is propelling the demand for effective burn ointments.
The growing number of burn injuries worldwide is a major factor contributing to the growth of the burn ointment market. An estimated 8,378,122 burn injuries occurred worldwide in 2019, corresponding to an age-standardized incidence rate of 118 per 100,000 people. More than two million people in the United States seek medical treatment for thermal burns each year, with about 75,000 of those cases requiring hospitalization and a third of those hospital stays lasting more than two months. In India, the annual incidence of burns varies from 700,000 to 800,000 cases with the majority of victims being women aged 16–35 years. More widespread loose-fitting clothing and unsafe kitchen environments have been contributing factors to accidental fires. Notably, about one-third of all burns in India result from clothing catching fire from open flames. The WHO African Region has the highest global rate for childhood burn deaths and the burn rates in the Western Pacific Region are 20 times higher than in the Americas. These statistics highlight the importance of developing effective burn care products/ointments for managing burn injuries in a variety of populations.
Moreover, the number of wildfire occurrences has increased as a result of global warming, intensifying burn-related health risks. A recent study found that climate change expanded the number of acres prone to wildfire risk by nearly 16%, resulting in greater exposure to toxic smoke particles and potential health issues. But a burn is among the wounds with a considerable number of cases worldwide demand and it needs suitable burn ointments for wound care, preventing infection, and promoting healing. As burn injuries remain prevalent across various demographics and regions, the demand for advanced burn care products continues to drive the market forward.
Restraint:
Allergic reactions and side effects associated with certain burn ointments can limit their usage among sensitive individuals.
Allergic reactions and adverse effects of burn ointments are serious challenges in the management of burn care. The medical complications associated with this range from simple skin contact reactions to debilitating dermatitis that may impede the service and healing process itself, leading to even more complicated medical scenarios. A study conducted in Northern India highlighted that 88% of cosmetic dermatitis cases occurred in females aged 20 to 49. While this study focused on cosmetics, it underscores the broader issue of topical product-induced dermatitis, which is pertinent to burn ointments as well. There are a lot of such reactions that require doctors and patients to take caution in choosing their burn ointments. Allergies and irritations to common agents must be avoided so that they do not aggravate the patient's condition. In addition, hypoallergenic formulations must be developed to meet the needs of sensitive individuals and minimize the occurrence of adverse reactions. Emphasizing patient safety and incompatibility of products will ensure that burn ointments address the varied needs of burn victims while limiting any deterioration due to possible allergic reactions.
Opportunity:
Advancements in burn ointment technology, such as the development of smart delivery systems, are enhancing treatment efficacy and expanding market potential.
These innovations in burn ointment technology offer a tremendous opportunity to help improve patient outcomes and conquer the worldwide burden of burn injuries. For example, these treatment tools could be composed of nanoparticles, such as silver and zinc oxide, and intracutaneous nanotechnology-enhanced dressings, which offer antimicrobial quality and wound healing. For example, hydrogel dressings imbued with silver nanoparticles have been found to speed up re-epithelialization whilst limiting scar formation. With over 1 million people in India facing moderate to severe burns every year, an effective way to treat them was the need of the hour. In Mumbai alone, burn injuries claimed over 700 lives over three years, outpacing deaths from diseases such as malaria or dengue.
Biological dressings and skin substitutes represent another advancement, utilizing materials such as amniotic membrane grafts that contain growth factors and extracellular matrix components to enhance wound healing and reduce scarring. Furthermore, sensor-enabled smart dressings are capable of monitoring wound healing by determining pH levels, temperature, and bacterial load allowing clinicians to assess wound healing and, subsequently, make accessible decisions regarding intervention and treatment as needed. These and other advances in burn ointments or related technology can potentially replete the standard of care, reduce mortality, and ultimately function to improve the quality of life for those who have experienced burns.
Challenge:
Maintaining sterility during ointment application poses significant challenges in both clinical and home settings.
Maintaining sterility during burn ointment application is crucial to prevent infections, yet it presents significant challenges in both clinical and home settings. Burn injuries are extremely prone to infections cause by the loss of the skin protective barrier. The infection rates are alarmingly high in burn patients, for example, one study found that 38.54% of the burn patients had wound-related infections. Even in clinical settings where strict infection control measures are employed, the probability of nosocomial infections is high. This risk is due to causes such as invasive procedures, longer hospital stays, and multidrug-resistant organisms. Research indicates that Pseudomonas infections were present in 57% of burn wound cases in certain units, highlighting the prevalence of such infections. The passage of microorganisms through the skin and mucosal linings of the body can lead to unimaginable injury, and in the home care environment, a sterile space is far more difficult to manage, as access to medical-grade configurations and education are often restricted. Patients and caregivers might not have adequate education and equipment to perform sterile ointment application, leading to the possibility of contamination. It is especially worrying since around 95% of burns happen in low- to middle-income countries that lack the resources and healthcare systems.
By Product
The topical antibiotics segment dominated the market with a revenue share of 33% in 2023. This dominance can be attributed to the high acceptance of topical antibiotic ointments like Neosporin and Polysporin in home-care settings. Government statistics indicate that burns are a common injury, with over 300 children treated daily in U.S. emergency departments, emphasizing the need for effective infection prevention measures that topical antibiotics provide. The U.S. FDA's approval of various antibiotic ointments for burn care further supports this segment's growth. As the incidence of burns increases globally, the demand for topical antibiotics is expected to rise. These ointments are crucial in preventing infections, which are a significant concern in burn injuries. The effectiveness of topical antibiotics in managing minor to moderate burns has made them a preferred choice among consumers, contributing to their market dominance.
The growth of the topical antibiotics segment is also influenced by advancements in wound care technology. Innovations such as hydrogel-based dressings and bioactive compounds have enhanced the healing process, but topical antibiotics remain essential for infection control. This balance between new technologies and traditional treatments ensures that topical antibiotics continue to hold a significant market share.
By Depth of Burn
In 2023, the minor burns segment accounted for the largest revenue share in the market. The most common type of burn injury is a minor burn affecting just the outermost layer of skin. There are nearly 1.2 million cases of blaze wounds in the United States each year, according to the National Center for Injury Prevention and Control; many of these wounds are insignificant blazes. The significant prevalence of mild burns, as well as the availability of over-the-counter burn ointments, drives this segment. Moreover, with the implementation of government initiatives for burn prevention and treatment, the growth of this segment is also strengthened. Minor burns are often treated at home, which increases the demand for easily accessible burn ointments. This growing acceptance paired with the utility of these ointments for managing small, minor burns without extensive medical visits has made these ointments a preferred consumer choice. Moreover, increasing awareness for burn care and the significance of immediate management of minor burns have further boosted the demand for burn ointments catering to minor burns. The preschool segment of burns minor burns is facilitated by the easy accessibility of burn ointments in retail pharmacies and online channels. This easy accessibility allows consumers to get minor burns treated quickly enough to minimize complications and support healing. The combination of accessibility and effectiveness has solidified the minor burns segment as a leading market segment.
By End-use
In 2023, the hospital segment accounted for the highest revenue share in the market. Hospitals are the first places where the most serious burns are treated, and they require special doorways and facilities. Government statistics show that roughly 40,000 patients are admitted to U.S. hospitals each year for partial burns, underscoring the important role of hospitals in burn treatment. The dominance of this segment is supported by the availability of advanced burn treatment options and specialized burn units in hospitals. The growing prevalence of such burns results in high hospitalization rates, which translates into a high market share for the hospital-based segment. Burns are treated in a surgical setting. Burn ointments in hospitals are very important to prevent infection and healing of severe burns. Ointments that apply to burns are used in hospitals where they are specifically trained to use that segment care to further the patient outcome. Technological advancements in burn treatment also matriculate the growth of the hospital segment. Bioengineered skin grafts and advanced wound dressings are examples of innovations that have significantly improved burn care outcomes. However, burn ointments are still indispensable for infection control and wound healing, and still have a critical place in the hospital setting.
In 2023, North America was the leading region with a 41% revenue share of the burn ointment market, due to the large healthcare infrastructure that is already established, as well as the popularization of burn safety. The U.S. was a major country in this market, propelled by strong competition centered around product innovation and strategic partnerships. The flow of North America can be ascribed to the advancement of medical facilities and the presence of the key market players. Strengthening market growth is the region's focus on treatment, prevention, and management of burns, with campaigns such as the American Burn Association's awareness drive. The Asia-Pacific region is expected to record the highest CAGR, owing to growing healthcare awareness and government initiatives supporting this trend. Another factor for the growth of this region is the presence of several underserved opportunities along with increasing incidences of burnout, particularly in countries like China and India. In contrast, the Asia-Pacific region's rapid growth is fueled by improving healthcare infrastructure and increasing demand for burn care products, making it a promising market for future expansion.
Johnson & Johnson
Mankind Pharma
Pfizer Inc.
Dr. Morepen
Smith & Nephew PLC
ConvaTec Group PLC
GlaxoSmithKline PLC (GSK)
Cipla Limited
Sun Pharmaceutical Industries Ltd.
Perrigo Company PLC
3M
Cardinal Health
Integra LifeSciences Corporation
Anika Therapeutics
B. Braun Melsungen AG
Kinetic Concepts, Inc.
Wisconsin Pharmacal Company
Julphar
Beiersdorf AG
The Mentholatum Company, Inc.
Recent Developments
In 2024, Bharat Serums and Vaccines entered an exclusive agreement with MediWound to introduce NexoBrid into India, expanding access to advanced burn treatment.
In 2023, ConvaTec entered the wound treatment market after acquiring Acelity to bolster its advanced wound care portfolio backed up with burn ointments.
Report Attributes | Details |
---|---|
Market Size in 2023 | USD 1.01 Billion |
Market Size by 2032 | USD 1.74 Billion |
CAGR | CAGR of 6.04% From 2024 to 2032 |
Base Year | 2023 |
Forecast Period | 2024-2032 |
Historical Data | 2020-2022 |
Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
Key Segments | • By Depth Of Burn (Minor Burns, Partial Thickness Burns, Full Thickness Burns) • By Product (Topical Antibiotics, Iodine, Silver, Others) • By End-use (Hospitals, Clinics, Others) |
Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia, Rest of Latin America) |
Company Profiles | Johnson & Johnson, Mankind Pharma, Pfizer Inc., Dr. Morepen, Smith & Nephew PLC, ConvaTec Group PLC, GlaxoSmithKline PLC (GSK), Cipla Limited, Sun Pharmaceutical Industries Ltd., Perrigo Company PLC, 3M, Cardinal Health, Integra LifeSciences Corporation, Anika Therapeutics, B. Braun Melsungen AG, Kinetic Concepts, Inc., Wisconsin Pharmacal Company, Julphar, Beiersdorf AG, The Mentholatum Company, Inc. |
Ans. The projected market size for the Burn Ointment Market is USD 1.71 billion by 2032.
Ans. The CAGR of the Burn Ointment Market is 6.04% during the forecast period of 2024-2032.
Ans: The North American region dominated the Burn Ointment Market in 2023.
Ans: The increasing incidence of burn injuries globally is propelling the demand for effective burn ointments.
Ans: The topical antibiotics segment dominated the Burn Ointment Market.
1. Introduction
1.1 Market Definition
1.2 Scope (Inclusion and Exclusions)
1.3 Research Assumptions
2. Executive Summary
2.1 Market Overview
2.2 Regional Synopsis
2.3 Competitive Summary
3. Research Methodology
3.1 Top-Down Approach
3.2 Bottom-up Approach
3.3. Data Validation
3.4 Primary Interviews
4. Market Dynamics Impact Analysis
4.1 Market Driving Factors Analysis
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PESTLE Analysis
4.3 Porter’s Five Forces Model
5. Statistical Insights and Trends Reporting
5.1 Incidence and Prevalence of Burns (2023)
5.2 Drug Volume: Production and Consumption
5.3 Healthcare Spending on Burn Treatment (2023)
5.4 Regional Regulatory Approvals & Compliance Trends
6. Competitive Landscape
6.1 List of Major Companies, By Region
6.2 Market Share Analysis, By Region
6.3 Product Benchmarking
6.3.1 Product specifications and features
6.3.2 Pricing
6.4 Strategic Initiatives
6.4.1 Marketing and promotional activities
6.4.2 Distribution and Supply Chain Strategies
6.4.3 Expansion plans and new product launches
6.4.4 Strategic partnerships and collaborations
6.5 Technological Advancements
6.6 Market Positioning and Branding
7. Burn Ointment Market Segmentation, By Depth Of Burn
7.1 Chapter Overview
7.2 Minor Burns
7.2.1 Minor Burns Market Trends Analysis (2020-2032)
7.2.2 Minor Burns Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3 Partial Thickness Burns
7.3.1 Partial Thickness Burns Market Trends Analysis (2020-2032)
7.3.2 Partial Thickness Burns Market Size Estimates and Forecasts to 2032 (USD Billion)
7.4 Full Thickness Burns
7.4.1 Full Thickness Burns Market Trends Analysis (2020-2032)
7.4.2 Full Thickness Burns Market Size Estimates and Forecasts to 2032 (USD Billion)
8. Burn Ointment Market Segmentation, By Product
8.1 Chapter Overview
8.2 Topical Antibiotics
8.2.1 Topical Antibiotics Market Trends Analysis (2020-2032)
8.2.2 Topical Antibiotics Market Size Estimates and Forecasts to 2032 (USD Billion)
8.3 Iodine
8.3.1 Iodine Market Trends Analysis (2020-2032)
8.3.2 Iodine Market Size Estimates and Forecasts to 2032 (USD Billion)
8.4 Silver
8.4.1 Silver Market Trends Analysis (2020-2032)
8.4.2 Silver Market Size Estimates and Forecasts to 2032 (USD Billion)
8.5 Others
8.5.1 Others Market Trends Analysis (2020-2032)
8.5.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
9. Burn Ointment Market Segmentation, By End-use
9.1 Chapter Overview
9.2 Hospitals
9.2.1 Hospitals Market Trends Analysis (2020-2032)
9.2.2 Hospitals Market Size Estimates and Forecasts to 2032 (USD Billion)
9.3 Clinics
9.3.1 Clinics Market Trends Analysis (2020-2032)
9.3.2 Clinics Market Size Estimates and Forecasts to 2032 (USD Billion)
9.4 Others
9.4.1 Others Market Trends Analysis (2020-2032)
9.4.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
10. Regional Analysis
10.1 Chapter Overview
10.2 North America
10.2.1 Trends Analysis
10.2.2 North America Burn Ointment Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.2.3 North America Burn Ointment Market Estimates and Forecasts, By Depth Of Burn (2020-2032) (USD Billion)
10.2.4 North America Burn Ointment Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.2.5 North America Burn Ointment Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.2.6 USA
10.2.6.1 USA Burn Ointment Market Estimates and Forecasts, By Depth Of Burn (2020-2032) (USD Billion)
10.2.6.2 USA Burn Ointment Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.2.6.3 USA Burn Ointment Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.2.7 Canada
10.2.7.1 Canada Burn Ointment Market Estimates and Forecasts, By Depth Of Burn (2020-2032) (USD Billion)
10.2.7.2 Canada Burn Ointment Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.2.7.3 Canada Burn Ointment Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.2.8 Mexico
10.2.8.1 Mexico Burn Ointment Market Estimates and Forecasts, By Depth Of Burn (2020-2032) (USD Billion)
10.2.8.2 Mexico Burn Ointment Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.2.8.3 Mexico Burn Ointment Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.3 Europe
10.3.1 Eastern Europe
10.3.1.1 Trends Analysis
10.3.1.2 Eastern Europe Burn Ointment Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.3.1.3 Eastern Europe Burn Ointment Market Estimates and Forecasts, By Depth Of Burn (2020-2032) (USD Billion)
10.3.1.4 Eastern Europe Burn Ointment Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.3.1.5 Eastern Europe Burn Ointment Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.3.1.6 Poland
10.3.1.6.1 Poland Burn Ointment Market Estimates and Forecasts, By Depth Of Burn (2020-2032) (USD Billion)
10.3.1.6.2 Poland Burn Ointment Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.3.1.6.3 Poland Burn Ointment Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.3.1.7 Romania
10.3.1.7.1 Romania Burn Ointment Market Estimates and Forecasts, By Depth Of Burn (2020-2032) (USD Billion)
10.3.1.7.2 Romania Burn Ointment Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.3.1.7.3 Romania Burn Ointment Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.3.1.8 Hungary
10.3.1.8.1 Hungary Burn Ointment Market Estimates and Forecasts, By Depth Of Burn (2020-2032) (USD Billion)
10.3.1.8.2 Hungary Burn Ointment Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.3.1.8.3 Hungary Burn Ointment Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.3.1.9 Turkey
10.3.1.9.1 Turkey Burn Ointment Market Estimates and Forecasts, By Depth Of Burn (2020-2032) (USD Billion)
10.3.1.9.2 Turkey Burn Ointment Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.3.1.9.3 Turkey Burn Ointment Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.3.1.10 Rest of Eastern Europe
10.3.1.10.1 Rest of Eastern Europe Burn Ointment Market Estimates and Forecasts, By Depth Of Burn (2020-2032) (USD Billion)
10.3.1.10.2 Rest of Eastern Europe Burn Ointment Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.3.1.10.3 Rest of Eastern Europe Burn Ointment Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.3.2 Western Europe
10.3.2.1 Trends Analysis
10.3.2.2 Western Europe Burn Ointment Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.3.2.3 Western Europe Burn Ointment Market Estimates and Forecasts, By Depth Of Burn (2020-2032) (USD Billion)
10.3.2.4 Western Europe Burn Ointment Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.3.2.5 Western Europe Burn Ointment Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.3.2.6 Germany
10.3.2.6.1 Germany Burn Ointment Market Estimates and Forecasts, By Depth Of Burn (2020-2032) (USD Billion)
10.3.2.6.2 Germany Burn Ointment Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.3.2.6.3 Germany Burn Ointment Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.3.2.7 France
10.3.2.7.1 France Burn Ointment Market Estimates and Forecasts, By Depth Of Burn (2020-2032) (USD Billion)
10.3.2.7.2 France Burn Ointment Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.3.2.7.3 France Burn Ointment Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.3.2.8 UK
10.3.2.8.1 UK Burn Ointment Market Estimates and Forecasts, By Depth Of Burn (2020-2032) (USD Billion)
10.3.2.8.2 UK Burn Ointment Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.3.2.8.3 UK Burn Ointment Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.3.2.9 Italy
10.3.2.9.1 Italy Burn Ointment Market Estimates and Forecasts, By Depth Of Burn (2020-2032) (USD Billion)
10.3.2.9.2 Italy Burn Ointment Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.3.2.9.3 Italy Burn Ointment Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.3.2.10 Spain
10.3.2.10.1 Spain Burn Ointment Market Estimates and Forecasts, By Depth Of Burn (2020-2032) (USD Billion)
10.3.2.10.2 Spain Burn Ointment Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.3.2.10.3 Spain Burn Ointment Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.3.2.11 Netherlands
10.3.2.11.1 Netherlands Burn Ointment Market Estimates and Forecasts, By Depth Of Burn (2020-2032) (USD Billion)
10.3.2.11.2 Netherlands Burn Ointment Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.3.2.11.3 Netherlands Burn Ointment Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.3.2.12 Switzerland
10.3.2.12.1 Switzerland Burn Ointment Market Estimates and Forecasts, By Depth Of Burn (2020-2032) (USD Billion)
10.3.2.12.2 Switzerland Burn Ointment Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.3.2.12.3 Switzerland Burn Ointment Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.3.2.13 Austria
10.3.2.13.1 Austria Burn Ointment Market Estimates and Forecasts, By Depth Of Burn (2020-2032) (USD Billion)
10.3.2.13.2 Austria Burn Ointment Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.3.2.13.3 Austria Burn Ointment Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.3.2.14 Rest of Western Europe
10.3.2.14.1 Rest of Western Europe Burn Ointment Market Estimates and Forecasts, By Depth Of Burn (2020-2032) (USD Billion)
10.3.2.14.2 Rest of Western Europe Burn Ointment Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.3.2.14.3 Rest of Western Europe Burn Ointment Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.4 Asia Pacific
10.4.1 Trends Analysis
10.4.2 Asia Pacific Burn Ointment Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.4.3 Asia Pacific Burn Ointment Market Estimates and Forecasts, By Depth Of Burn (2020-2032) (USD Billion)
10.4.4 Asia Pacific Burn Ointment Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.4.5 Asia Pacific Burn Ointment Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.4.6 China
10.4.6.1 China Burn Ointment Market Estimates and Forecasts, By Depth Of Burn (2020-2032) (USD Billion)
10.4.6.2 China Burn Ointment Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.4.6.3 China Burn Ointment Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.4.7 India
10.4.7.1 India Burn Ointment Market Estimates and Forecasts, By Depth Of Burn (2020-2032) (USD Billion)
10.4.7.2 India Burn Ointment Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.4.7.3 India Burn Ointment Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.4.8 Japan
10.4.8.1 Japan Burn Ointment Market Estimates and Forecasts, By Depth Of Burn (2020-2032) (USD Billion)
10.4.8.2 Japan Burn Ointment Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.4.8.3 Japan Burn Ointment Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.4.9 South Korea
10.4.9.1 South Korea Burn Ointment Market Estimates and Forecasts, By Depth Of Burn (2020-2032) (USD Billion)
10.4.9.2 South Korea Burn Ointment Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.4.9.3 South Korea Burn Ointment Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.4.10 Vietnam
10.4.10.1 Vietnam Burn Ointment Market Estimates and Forecasts, By Depth Of Burn (2020-2032) (USD Billion)
10.4.10.2 Vietnam Burn Ointment Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.4.10.3 Vietnam Burn Ointment Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.4.11 Singapore
10.4.11.1 Singapore Burn Ointment Market Estimates and Forecasts, By Depth Of Burn (2020-2032) (USD Billion)
10.4.11.2 Singapore Burn Ointment Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.4.11.3 Singapore Burn Ointment Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.4.12 Australia
10.4.12.1 Australia Burn Ointment Market Estimates and Forecasts, By Depth Of Burn (2020-2032) (USD Billion)
10.4.12.2 Australia Burn Ointment Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.4.12.3 Australia Burn Ointment Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.4.13 Rest of Asia Pacific
10.4.13.1 Rest of Asia Pacific Burn Ointment Market Estimates and Forecasts, By Depth Of Burn (2020-2032) (USD Billion)
10.4.13.2 Rest of Asia Pacific Burn Ointment Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.4.13.3 Rest of Asia Pacific Burn Ointment Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.5 Middle East and Africa
10.5.1 Middle East
10.5.1.1 Trends Analysis
10.5.1.2 Middle East Burn Ointment Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.5.1.3 Middle East Burn Ointment Market Estimates and Forecasts, By Depth Of Burn (2020-2032) (USD Billion)
10.5.1.4 Middle East Burn Ointment Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.5.1.5 Middle East Burn Ointment Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.5.1.6 UAE
10.5.1.6.1 UAE Burn Ointment Market Estimates and Forecasts, By Depth Of Burn (2020-2032) (USD Billion)
10.5.1.6.2 UAE Burn Ointment Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.5.1.6.3 UAE Burn Ointment Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.5.1.7 Egypt
10.5.1.7.1 Egypt Burn Ointment Market Estimates and Forecasts, By Depth Of Burn (2020-2032) (USD Billion)
10.5.1.7.2 Egypt Burn Ointment Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.5.1.7.3 Egypt Burn Ointment Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.5.1.8 Saudi Arabia
10.5.1.8.1 Saudi Arabia Burn Ointment Market Estimates and Forecasts, By Depth Of Burn (2020-2032) (USD Billion)
10.5.1.8.2 Saudi Arabia Burn Ointment Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.5.1.8.3 Saudi Arabia Burn Ointment Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.5.1.9 Qatar
10.5.1.9.1 Qatar Burn Ointment Market Estimates and Forecasts, By Depth Of Burn (2020-2032) (USD Billion)
10.5.1.9.2 Qatar Burn Ointment Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.5.1.9.3 Qatar Burn Ointment Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.5.1.10 Rest of Middle East
10.5.1.10.1 Rest of Middle East Burn Ointment Market Estimates and Forecasts, By Depth Of Burn (2020-2032) (USD Billion)
10.5.1.10.2 Rest of Middle East Burn Ointment Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.5.1.10.3 Rest of Middle East Burn Ointment Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.5.2 Africa
10.5.2.1 Trends Analysis
10.5.2.2 Africa Burn Ointment Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.5.2.3 Africa Burn Ointment Market Estimates and Forecasts, By Depth Of Burn (2020-2032) (USD Billion)
10.5.2.4 Africa Burn Ointment Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.5.2.5 Africa Burn Ointment Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.5.2.6 South Africa
10.5.2.6.1 South Africa Burn Ointment Market Estimates and Forecasts, By Depth Of Burn (2020-2032) (USD Billion)
10.5.2.6.2 South Africa Burn Ointment Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.5.2.6.3 South Africa Burn Ointment Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.5.2.7 Nigeria
10.5.2.7.1 Nigeria Burn Ointment Market Estimates and Forecasts, By Depth Of Burn (2020-2032) (USD Billion)
10.5.2.7.2 Nigeria Burn Ointment Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.5.2.7.3 Nigeria Burn Ointment Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.5.2.8 Rest of Africa
10.5.2.8.1 Rest of Africa Burn Ointment Market Estimates and Forecasts, By Depth Of Burn (2020-2032) (USD Billion)
10.5.2.8.2 Rest of Africa Burn Ointment Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.5.2.8.3 Rest of Africa Burn Ointment Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.6 Latin America
10.6.1 Trends Analysis
10.6.2 Latin America Burn Ointment Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.6.3 Latin America Burn Ointment Market Estimates and Forecasts, By Depth Of Burn (2020-2032) (USD Billion)
10.6.4 Latin America Burn Ointment Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.6.5 Latin America Burn Ointment Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.6.6 Brazil
10.6.6.1 Brazil Burn Ointment Market Estimates and Forecasts, By Depth Of Burn (2020-2032) (USD Billion)
10.6.6.2 Brazil Burn Ointment Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.6.6.3 Brazil Burn Ointment Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.6.7 Argentina
10.6.7.1 Argentina Burn Ointment Market Estimates and Forecasts, By Depth Of Burn (2020-2032) (USD Billion)
10.6.7.2 Argentina Burn Ointment Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.6.7.3 Argentina Burn Ointment Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.6.8 Colombia
10.6.8.1 Colombia Burn Ointment Market Estimates and Forecasts, By Depth Of Burn (2020-2032) (USD Billion)
10.6.8.2 Colombia Burn Ointment Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.6.8.3 Colombia Burn Ointment Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.6.9 Rest of Latin America
10.6.9.1 Rest of Latin America Burn Ointment Market Estimates and Forecasts, By Depth Of Burn (2020-2032) (USD Billion)
10.6.9.2 Rest of Latin America Burn Ointment Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.6.9.3 Rest of Latin America Burn Ointment Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
11. Company Profiles
11.1 Johnson & Johnson
11.1.1 Company Overview
11.1.2 Financial
11.1.3 Products/ Services Offered
11.1.4 SWOT Analysis
11.2 Mankind Pharma
11.2.1 Company Overview
11.2.2 Financial
11.2.3 Products/ Services Offered
11.2.4 SWOT Analysis
11.3 Pfizer Inc.
11.3.1 Company Overview
11.3.2 Financial
11.3.3 Products/ Services Offered
11.3.4 SWOT Analysis
11.4 Dr. Morepen
11.4.1 Company Overview
11.4.2 Financial
11.4.3 Products/ Services Offered
11.4.4 SWOT Analysis
11.5 Smith & Nephew PLC
11.5.1 Company Overview
11.5.2 Financial
11.5.3 Products/ Services Offered
11.5.4 SWOT Analysis
11.6 ConvaTec Group PLC
11.6.1 Company Overview
11.6.2 Financial
11.6.3 Products/ Services Offered
11.6.4 SWOT Analysis
11.7 GlaxoSmithKline PLC (GSK)
11.7.1 Company Overview
11.7.2 Financial
11.7.3 Products/ Services Offered
11.7.4 SWOT Analysis
11.8 Cipla Limited
11.8.1 Company Overview
11.8.2 Financial
11.8.3 Products/ Services Offered
11.8.4 SWOT Analysis
11.9 Sun Pharmaceutical Industries Ltd.
11.9.1 Company Overview
11.9.2 Financial
11.9.3 Products/ Services Offered
11.9.4 SWOT Analysis
11.10 Perrigo Company PLC
11.10.1 Company Overview
11.10.2 Financial
11.10.3 Products/ Services Offered
11.10.4 SWOT Analysis
12. Use Cases and Best Practices
13. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
By Depth Of Burn
Minor Burns
Partial Thickness Burns
Full Thickness Burns
By Product
Topical Antibiotics
Iodine
Silver
Others
By End-use
Hospitals
Clinics
Others
Request for Segment Customization as per your Business Requirement: Segment Customization Request
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
Detailed Volume Analysis
Criss-Cross segment analysis (e.g. Product X Application)
Competitive Product Benchmarking
Geographic Analysis
Additional countries in any of the regions
Customized Data Representation
Detailed analysis and profiling of additional market players
Leukemia Therapeutics Market Size was valued at USD 17.2 Billion in 2023 and is expected to reach USD 32.3 Billion by 2032, growing at a CAGR of 7.3% over the forecast period 2024-2032.
Ophthalmology PACS Market was valued at USD 156.39 billion in 2023 and is expected to reach USD 311.31 billion by 2032, growing at a CAGR of 8.02% from 2024-2032.
Apoptosis Assay Market was valued at USD 5.77 billion in 2023 and is expected to reach USD 12.86 billion by 2032, growing at a CAGR of 9.37% from 2024 to 2032.
The Internet of Things in Healthcare Market Size was valued at USD 133.72 billion in 2023 and is expected to reach USD 668.98 billion by 2032 and grow at a CAGR of 19.61% over the forecast period 2024-2032.
The Compression Therapy Market size was valued at USD 4.06 Billion in 2023 & is estimated to reach USD 7.86 Billion by 2032 with a growing CAGR of 7.63% over the forecast period of 2024-2032.
Downstream Processing Market was valued at USD 29.35 billion in 2023 and is expected to reach USD 99.64 billion by 2032, growing at a CAGR of 14.60%.
Hi! Click one of our member below to chat on Phone